We studied beardogs and brewed our own lava. We designed a vortex laser to accelerate computing. We challenged the status quo when it comes to treating concussions, and we helped show why bite-mark analysis may not be a reliable form of evidence to use in criminal courts.
AMP has published guideline recommendations for both clinical laboratory professionals and oncologists that assess the status of next-generation sequencing (NGS)-based cancer tests and establish standardized classification, annotation, interpretation, and reporting conventions for somatic sequence variants.
Modeling blood flow through a stent graft put graduate student John Asiruwa on the path to a career in biomedical engineering, doing work that “can be life changing for patients.”
A ‘living bandage’ made from stem cells, which could revolutionise the treatment and prognosis of a common sporting knee injury, has been trialled in humans for the first time by scientists at the Universities of Liverpool and Bristol.
Gene variants associated with disease are typically considered faulty; problems arise when the proteins they make don't adequately carry out their designated role.
UT Southwestern Medical Center researchers developed a new imaging technique that makes X-ray images of proteins as they move in response to electric field pulses.
Biology isn't just for biologists anymore. That's nowhere more apparent than in the newly furnished lab in room 097 of the Shriram Center basement, where flasks of bacterial and animal cells, snug in their incubators, are churning out proteins destined for jobs they may not have done in nature.
Protecting the body against oxidative stress
Glenn Fleisig compiles biomechanical analysis from thousands of baseball players to find out what's behind the epidemic.
A biologist at The University of Texas at Dallas and his colleagues have discovered that two enzymes previously linked independently with keeping cancer cells alive actually work in tandem to spur tumor growth.
Scientists from the McEwen Centre for Regenerative Medicine, University Health Network, have developed the first functional pacemaker cells from human stem cells, paving the way for alternate, biological pacemaker therapy.
Cancer is the second leading cause of death in the U.S., making early, reliable diagnosis and treatment a priority. Miniaturized lab-on-chip approaches are prime candidates for developing viable diagnostic tests and instruments because they are small, need only limited test volumes, and can be cost-effective. Researchers have developed just such an approach capable of processing biomolecular samples from blood. They describe their work in this week’s Biomicrofluidics.
Dr. Delbert E. Day, a prolific inventor whose work with specialty glasses has led to treatments for cancer, bone tissue regeneration and wound care, has been named a National Academy of Inventors Fellow.
It has been 20 years since Dolly the sheep was successfully cloned in Scotland, but cloning mammals remains a challenge. A new study by researchers from the U.S. and France of gene expression in developing clones now shows why most cloned embryos likely fail.
New research led by scientists at The Scripps Research Institute (TSRI) reveals that a human enzyme has changed little from its days as a bacterial enzyme.
A team of scientists has uncovered details of the cellular mechanisms that control the direct programming of stem cells into motor neurons.
Scientists examined one bacterium found 1,000 feet underground (called Paenibacillus) that demonstrated resistance to most antibiotics used today, including so-called ‘drugs of last resort’ such as daptomycin. These microorganisms have been isolated from the outside world for more than four million years within the cave.
Prominent research leader and biomedical scientist Professor Barry Halliwell will help to steer biomedical research efforts in Singapore at the Agency for Science, Technology and Research (A*STAR) from 1 January 2017.
A Queen’s University Belfast expert is leading a €4m international initiative to investigate whether natural toxins and manmade chemicals are creating potentially dangerous mixtures that affect our natural hormones and cause major illnesses such as cancer, obesity, diabetes or infertility.
The patent relates to the use of Streck’s proprietary Cell-Free DNA BCT CE product for the collection of samples to analyze fetal nucleic acid for non-invasive prenatal testing (NIPT).
RSS
Medicine keyboard_arrow_right
Sciencekeyboard_arrow_right
Life keyboard_arrow_right
Business keyboard_arrow_right
Journal News keyboard_arrow_right
By Location keyboard_arrow_right
Meetings, Grants, and Events keyboard_arrow_right